Pharmacodynamic Drug-Drug Interactions Considered to be Added in the List of Contraindications with Pharmacological Classification in Korea |
Je, Nam Kyung
(College of Pharmacy, Pusan National University)
Kim, Dong-Sook (Research Department, Health Insurance Review & Assessment Service) Kim, Grace Juyun (Department of Biomedical Science, College of Medicine, Seoul National University) Lee, Sukhyang (College of Pharmacy, Ajou University) |
1 | Sandusky M. Michigan drug utilization review and OBRA 90. Mich Med 1993;92:38-9. |
2 | Heo JH, Suh DC, Kim S, et al. Evaluation of the pilot program on the real-time drug utilization review system in South Korea. Int J Med Inform 2013. |
3 | Park JY, Park KW. The contraindication of comedication drugs and drug utilization review. J Korean Med Assoc 2012;55:484-90. DOI |
4 | Yakup Shinmoon. Sep 25, 2003. Available from https://yakup.com/news/index.html?mode=view&pmode=&cat=all&cat2=&cat3=&nid=27184&num_start=110055. Accessed March 15, 2015. |
5 | National Archives of Korea. Korean drug utilization review system. November 2014. Available from http://www.archives.go.kr/next/search/listSubjectDescription.do?id=009535&pageFlag=. Accessed February26, 2015. |
6 | Korea Institute of Drug Safety & Risk Management. Press Release. March 2015. http://www.drugsafe.or.kr/iwt/ds/ko/bbs/EgovBbs.do;jsessionid=922bNDgoNDGmJjtslPQHj36aeEYEWsVQF9oanjSQOTSgNLzuqjxs1EKagcK801cl.webint_2_servlet_engine1?bbsId=BBSMSTR _000000000101&nttId=1315&pageIndex=1&searchCnd=&search- Wrd=. Accessed March 15, 2015. |
7 | Ministry of Food and Drug Safety. Press Release. March 2015. http://www.mfds.go.kr/index.do?mid=688&seq=26716. Accessed March 15, 2015. |
8 | Cascorbi I. Drug interactions--principles, examples and clinical consequences. Dtsch Arztebl Int 2012;109:546-55; quiz 56. |
9 | Strandell J, Wahlin S. Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database. Eur J Clin Pharm 2011;67:633-41. DOI |
10 | Drug interactions result from a number of underlying pharmacokinetic and pharmacodynamic mechanisms. Drugs Ther Perspect 2013;29: 217-22. DOI |
11 | Thompson R. PPI therapy: Clopidrogel-PPI drug interaction may not be a class effect. Nat Rev Gastroenterol Hepatol 2011;8(6):302. |
12 | Rolan PE. Drug Interactions with Triptans. CNS Drugs 2012;26:949-57. DOI |
13 | Mehrotra N, Gupta M, Kovar A, et al. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy. Int J Impot Res 2007;19:253-64. DOI |
14 | Paterno MD, Maviglia SM, Gorman PN, et al. Tiering drug-drug interaction alerts by severity increases compliance rates. J Am Med Inform Assoc 2009;16:40-6. DOI |